IL33 and androgen insensitivity syndrome: However, previous research has shown that serum IL-33 levels are significantly higher (P < 0.001) in patients with AIS [57.68 ng/L (IQR, 44.95–76.73)] compared to healthy controls [47.48 ng/L (IQR, 38.67–53.78)] (30).